Home Therapeutics Combination Therapies

Combination Therapies

Random
Woman used shield with breast cancer logo for protect cancer cell.
Combination Therapies

Breast Cancer Fight Gets Aid from Immunotherapy and Diabetes Drug Combo

Combination Therapies

Plexxikon, Merck Partner on Combination Therapy Trial

Combination Therapies

Epigenetic Checkpoint Control Could Boost T-Cell Antitumor Activity

Combination Therapies

Regeneron, Bayer Ink Potentially $65M+ Wet AMD Combo Treatment Deal

Combination Therapies

RNAi-Chemo Tag Team Slams Ovarian Cancer

Combination Therapies

FDA Approves Tecentriq-Abraxane Combo as First Immunotherapy Regimen for Breast Cancer

Scientists devised a pinpointed immunotherapy regimen—intratumoral delivery of a TLR9 ligand with OX40 activation to ramp up T-cell responses—that eradicated tumors throughout the body in mice. [Sagiv-Barfi et al.
Combination Therapies

Local Immunotherapy Shrinks Tumors Near and Far

Combination Therapies

Combo Therapy Efficiently Creates Enduring Memory T Cells

T cells around a cancer cell
Combination Therapies

Novel Combination Therapy Potentially Combats Mutating Cancers

Cancer immunotherapy via checkpoint inhibition may be improved now that a key target
Combination Therapies

Checkpoint Protein Propped Up by Cell-Surface Sidekick

123...5Page 1 of 5
Copyright © 2021 Genetic Engineering & Biotechnology News. All Rights Reserved.